Thornal was president and CEO of spinal cord stimulation company Nevro from April 2023 until it was acquired by Globus Medical last month for about $250 million. Before that, he was group ...

Additionally, the analyst acknowledged that the performance of Nevro and Emerging Technologies could provide some support to Globus Medical’s Spine business. However, there is a belief that even ...

MILAN (Reuters) -The United States has warned Pirelli that sales of vehicles fitted with its data-collecting technology could be restricted due to concerns over the influence on the tyremaker of ...

Most recently, he served as CEO and president of Nevro, which fellow orthopedic giant Globus Medical acquired earlier this year. Prior to that, Thornal spent nine years at Hologic, culminating in ...

Thornal was president and CEO of spinal cord stimulation company Nevro from April 2023 until it was acquired by Globus Medical last month for about $250 million. Before that, he was group president of ...

Mr. Thornal will join the company July 1. He was previously CEO and president of Nevro, which was acquired by Globus Medical in April. He also worked at Hologic for nine years and held several ...

Medical device maker Masimo said Tuesday that it does not expect a cyberattack it disclosed earlier this month to have a material effect on its fiscal 2025 revenue, nor does it expect the incident to ...

Abbott (NYSE: ABT) + announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The TMVR system offers an option for patients with mitral ...

Here are 10 key developments from Zimmer Biomet so far in 2025. 1. The company entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on ...

The field of renal denervation remains challenged by the inability to confirm successful ablation of the targeted renal sympathetic nerves. The availability of technology to measure regional blood ...